Translational Development AcquisitionTDACUInstitutional Ownership
NASDAQTDACU
$11.48▲
+0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST
Institutions by Trading Activity
3Institutions
Increased133.3%
Unchanged00.0%
Reduced266.7%
Ownership Statistics
13F · as of 30 Jun, 2026
Institutional Ownership
—
not available
Shares Held by Institutions
32.34K
of 0 outstanding
▼-95.99%
QoQ
Shares Outstanding
0
Institutional Investors
3
filed 13F for Jun 2026
▼-2 vs prior quarter
Net Shares Added (QoQ)
-775.09K
distributed since last quarter
Value of Holdings
$371.27K
reported market value
Shares Owned by Institutions
Shares held% of outstanding
Latest—
Average ownership—
Peak ownership—
Shares Purchased/Sold by Institutions
AccumulatedDistributed
Latest quarter—
Net over range—
Accumulating quarters—
Ownership Summary
Updated
Translational Development Acquisition Corp. (NASDAQ:TDACU) appeared in the 13F filings of 3 institutional investors for the quarter ended June 30, 2026.
Total shares held in Translational Development Acquisition fell 95.99% from Q1 2026, while the number of holders fell 66.67% from Q2 2025.
Of the 3 holders of TDACU in Q2 2026, 1 added to its position and 2 reduced their stakes.
Altogether, institutional holders owned 32.34K TDACU shares at the end of Q2 2026, down 775.09K from the prior quarter and down 2.36Mn from a year earlier.
Clear Street Group Inc. led 13F holders of TDACU with 12.34K shares as of June 30, 2026.
On the other side, among holders that kept a position in Translational Development Acquisition, the largest reductions in Q2 2026 came from Flow Traders U.S. LLC (-2.43K shares) and UBS Group AG (-1 share).
Per Business Quant data, the 3 largest holders of Translational Development Acquisition at the end of Q2 2026 were Clear Street Group Inc. (12.34K shares), Flow Traders U.S. LLC (11.66K shares) and UBS Group AG (8.34K shares).